ArticleSAGE open medicine2019
Lung cancer screening patient-provider discussion: Where do we stand and what are the associated factors?
Article in SAGE open medicine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
12 citing papers in PubMed.
- Assessing Factors Associated With Patient-Provider Discussions About Lung Cancer Screening Using Andersen's Behavioral Model of Health Services Utilization.Clinical lung cancer · 2025Article
- Association of Telehealth Encounters With Lung Cancer Screening Consultation in the U.S.: Preliminary Results.AJPM focus · 2025Article
- Patient-clinician discussions on lung cancer screening in the United States before and after 2021 guidelines.Translational behavioral medicine · 2025Article
- Review
- Knowledge, Attitudes, and Practice Patterns of Lung Cancer Screening Among Physicians in Saudi Arabia.Cureus · 2024Article
- Lung Cancer Screening in People With HIV: A Mixed-Methods Study of Patient and Provider Perspectives.American journal of preventive medicine · 2023Article
- Opportunities and Challenges in Lung Cancer Screening Implementation: A Narrative Review.Current challenges in thoracic surgery · 2023Article
- Examining trends in health care access measures among low-income adult smokers in Ohio: 2012-2019.Preventive medicine reports · 2023Article
- Neutral Desorption Extractive Electrospray Ionization Mass Spectrometry Analysis Sputum for Non-Invasive Lung Adenocarcinoma Detection.OncoTargets and therapy · 2021Article
- Geographic Variation in Overscreening for Colorectal, Cervical, and Breast Cancer Among Older Adults.JAMA network open · 2020Article
- Race, Educational Attainment, and E-Cigarette Use.Journal of medical research and innovation · 2020Article
- Combined Effects of Race and Socioeconomic Status on Cancer Beliefs, Cognitions, and Emotions.Healthcare (Basel, Switzerland) · 2019Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveThe primary objective of this study was to estimate the percentage of individuals possibly eligible for lung cancer screening that report having discussed screening with a health care provider. The secondary objective was to investigate the associated factors of having patient-provider lung cancer screening discussion.
methodsData from the Health Information National Trends Survey 2017 were used (
resultsOnly 12.24% of individuals potentially eligible for lung cancer screening report prior discussion regarding lung cancer screening with a health care provider. Being eligible for lung cancer screening based on Centers for Medicare and Medicaid Services eligibility criteria was positively associated with the odds of a patient-provider lung cancer screening discussion (odds ratio = 3.95, 95% confidence interval = 2.48-6.30). Unlike gender, race, education, or insurance coverage, a usual source of health care was positively associated with a patient-provider screening discussion (odds ratio = 2.48, 95% confidence interval = 1.31-4.70).
conclusionIndividuals potentially eligible for lung cancer screening are more likely to have screening discussions with a health care provider. Having a usual source of health care may increase the odds of such a discussion, while patients are not discriminated based on race, gender, education, and insurance coverage. However, the relatively low rate (12.24%) of reported patient-provider lung cancer screening discussion indicates that significant barriers still remain.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.